Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Oliviero, Barbara ^a   Varchetta, Stefania ^a   Paudice, Enrica ^a   Michelone, Giuseppe ^b   Zaramella, Marco ^b   Mavilio, Domenico ^c   De Filippi, Francesca ^d   Bruno, Savino ^d   Mondelli, Mario U ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 21; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL KILLER CELL IG LIKE RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 69249113887     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.047     Document Type: Article

References (53)

1. Wieland S.F., and Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79 (2005) 9369-9380
2. Cheng G., Zhong J., and Chisari F.V. Inhibition of dsRNA-induced signalling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103 (2006) 8499-8504
3. Loo Y.M., Owen D.M., Li K., et al. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103 (2006) 6001-6006
4. Foy E., Li K., Wang C.Y., et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
5. Johnson C.L., Owen D.M., and Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 282 (2007) 10792-10803
6. Kakimi K., Guidotti L.G., Koezuka Y., et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192 (2000) 921-930
7. Vilarinho S., Ogasawara K., Nishimura S., et al. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A 104 (2007) 18187-18192
8. Vivier E., Tomasello E., Baratin M., et al. Functions of natural killer cells. Nat Immunol 9 (2008) 503-510
9. Caligiuri M.A. Human natural killer cells. Blood 112 (2008) 461-469
10. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
11. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
12. Morishima C., Paschal D.M., Wang C.C., et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43 (2006) 573-580
13. Golden-Mason L., Madrigal-Estebas L., McGrath E., et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57 (2008) 1121-1128
14. Tseng C.T., and Klimpel G.R. Binding of hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (2002) 43-49
15. Crotta S., Stilla A., Wack A., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195 (2002) 35-42
16. Corado J., Toro F., Rivera H., et al. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 109 (1997) 451-457
17. Pár G., Rukavina D., Podack E.R., et al. Decrease in CD3-negative-CD8dim(+) and VΔ2/Vγ9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 37 (2002) 514-522
18. Meier U.C., Owen R.E., Taylor E., et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 79 (2005) 12365-12374
19. Nattermann J., Feldmann G., Ahlenstiel G., et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55 (2006) 869-877
20. Szabo G., Chang S., and Dolganiuc A. Altered innate immunity in chronic hepatitis C infection-cause or effect?. Hepatology 46 (2007) 1279-1290
21. Varchetta S., Oliviero B., Donato M.F., et al. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection after liver transplantation. J Hepatol 50 (2009) 314-322
22. Pala P., Hussell T., and Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243 (2000) 107-124
23. Strengell M., Matikainen S., Siren J., et al. IL-21 in synergy with IL-15 and IL-18 enhances IFN-γ production in human NK and T cells. J Immunol 170 (2003) 5464-5469
24. Parrish-Novak J., Dillon S.R., Nelson A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63
25. Bryceson Y.T., March M.E., Ljunggren H.G., et al. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214 (2006) 73-91
26. Betts M.R., Benchley J.M., Price D.A., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 (2003) 65-78
27. Rehermann B., and Naoumov N.V. Immunological techniques in viral hepatitis. J Hepatol 46 (2007) 508-520
28. Alter G., Malenfant J., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 (2004) 15-22
29. Perez-Villar J.J., Melero I., Rodriguez A., et al. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 154 (1995) 5779-5788
30. O'Connor G.M., Guiran K.J., Cunningham R.T., et al. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178 (2007) 235-241
31. Carr W.H., Rosen D.B., Arase H., et al. KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178 (2007) 647-651
32. Martin M.P., Gao X., Lee J.H., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Get 31 (2002) 429-434
33. Qi Y., Martin M.P., Gao X., et al. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2 (2006) e79
34. De Maria A., Fogli M., Mazza S., et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37 (2007) 445-455
35. Duesberg U., Schneiders A.M., Fliegers D., et al. Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J Hepatol 35 (2001) 650-657
36. Yoon J.C., Shiina M., Ahlenstiel G., et al. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49 (2009) 12-21
37. Clausen J., Vergeiner B., Enk M., et al. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 207 (2003) 85-93
38. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781-790
39. Burgess S.J., Maasho K., Madhan M., et al. The NKG2D receptor: immunobiology and clinical implications. Immunol Res 40 (2008) 18-34
40. Bauer S., Groh V., Wu J., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
41. Cosman D., Mullberg J., Sutherland C.L., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
42. Chen Y., Wei H., Sun R., et al. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46 (2007) 706-715
43. Zhang S., Hüe S., Sène D., et al. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-β in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?. J Infect Dis 197 (2008) 1341-1349
44. Guidotti L.G., and Chisari F.V. Non-cytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19 (2001) 65-91
45. Liu C., Zhu H., Tu Z., et al. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 37 (2003) 1335-1342
46. Wang S.H., Huang C.X., Ye L., et al. Natural killer cells suppress full cycle HCV infection of human hepatocytes. J Viral Hepat 15 (2008) 855-864
47. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
48. Accapezzato D., Francavilla V., Paroli M., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T-cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
49. Liu C., Zhu H., Tu Z., et al. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 37 (2003) 1335-1342
50. Kasahara S., Ando K., Saito K., et al. Lack of tumor necrosis factor α induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 77 (2003) 2469-2476
51. Esteve M., Saro C., González-Huix F., et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 53 (2004) 1363-1365
52. Dunn C., Brunetto M.R., Reynolds G., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204 (2008) 667-680
53. Fattovich G., Bortolotti F., and Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48 (2008) 335-352